Popular Weight Loss Medication May Benefit 93 Million U.S. Adults, UC Irvine Study Found
August 17, 2023
August 17, 2023
IRVINE, California, Aug. 17 (TNSres) -- The University of California Irvine campus issued the following news release:
* * *
Semaglutide medication may also prevent heart attack, stroke
* * *
A projected 93 million U.S. adults who are overweight and obese may be suitable for the 2.4 mg dosage of semaglutide, a weight loss medication known under the brand name Wegovy, a University of California, Irvine study has found.
The researcher . . .
* * *
Semaglutide medication may also prevent heart attack, stroke
* * *
A projected 93 million U.S. adults who are overweight and obese may be suitable for the 2.4 mg dosage of semaglutide, a weight loss medication known under the brand name Wegovy, a University of California, Irvine study has found.
The researcher . . .